frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome

Rare Disease

MONDO:0013271

Also known as:

ALX1-related frontonasal dysplasiafrontonasal dysplasia type 3FND3

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases

Companies Active in frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome

1 company

Organizations with orphan designations or approved therapies for this disease

Takeda Pharmaceuticals U.S.A., Inc.

Other

Designated

View all companies